MedTrace Logo

Manipulating Tobacco Constituents in Female Menthol Smokers

NCT02048852 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 381

Last updated 2021-03-19

No results posted yet for this study

Summary

This study examines the potential effect of reducing nicotine content or menthol or both in women of reproductive age, a vulnerable population identified by the FDA in need of further research.

Conditions

  • Nicotine Dependence

Interventions

OTHER

Reduced Nicotine Content- Non Menthol

Switch from own brand of cigarette to a research cigarette with a Reduced Nicotine Content of 0.07mg nicotine yield without menthol.

OTHER

Reduced Nicotine Content- Menthol

Switch from own brand of cigarette to Reduced nicotine level of each research cigarette to 0.07mg nicotine yield with Menthol

OTHER

Conventional Nicotine Content- Menthol

Allow own brand of Conventional Nicotine-Menthol Cigarette

OTHER

Conventional Nicotine Content- Non Menthol

Switch from own cigarette to a research cigarette which contains Conventional Nicotine yield.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • UConn Health

    lead OTHER

Principal Investigators

  • Cheryl A Oncken, MD MPH · UCONN Health Center

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2020-03-31
Completion
2020-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02048852 on ClinicalTrials.gov